The role of ω-3 PUFA supplementation in the prevention of cancer metastasis was demonstrated in clinical studies in BC patients using ω-3 PUFAs in conjunction with antitumor drugs and mastectomy, and showed decreases in the presence of the proliferative marker Ki67 and the angiogenesis marker VEGF [73]. The gene discussed is MKI67; the disease is cancer.